Similar articles for PMID: 16447120

Year	Number of Results
2001	3
2003	3
2004	2
2005	6
2006	13
2007	6
2008	3
2009	2
2010	5
2011	13
2012	3
2013	1
2014	4
2015	11
2016	10
2017	7
2018	3
2019	5
2020	1
2021	2
2022	3
2024	0

1

Models for integrating buprenorphine therapy into the primary HIV care setting.

Basu S, Smith-Rohrberg D, Bruce RD, Altice FL. Basu S, et al. Clin Infect Dis. 2006 Mar 1;42(5):716-21. doi: 10.1086/500200. Epub 2006 Jan 24. Clin Infect Dis. 2006. PMID: 16447120

2

Initial strategies for integrating buprenorphine into HIV care settings in the United States.

Sullivan LE, Bruce RD, Haltiwanger D, Lucas GM, Eldred L, Finkelstein R, Fiellin DA. Sullivan LE, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S191-6. doi: 10.1086/508183. Clin Infect Dis. 2006. PMID: 17109306 Review.

3

Buprenorphine and HIV primary care: new opportunities for integrated treatment.

Khalsa J, Vocci F, Altice F, Fiellin D, Miller V. Khalsa J, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S169-72. doi: 10.1086/508179. Clin Infect Dis. 2006. PMID: 17109302 Review.

4

Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.

Weiss L, Netherland J, Egan JE, Flanigan TP, Fiellin DA, Finkelstein R, Altice FL; BHIVES Collaborative. Weiss L, et al. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S68-75. doi: 10.1097/QAI.0b013e31820a8226. J Acquir Immune Defic Syndr. 2011. PMID: 21317597

5

The medical management of opioid dependence in HIV primary care settings.

Lum PJ, Tulsky JP. Lum PJ, et al. Curr HIV/AIDS Rep. 2006 Nov;3(4):195-204. doi: 10.1007/s11904-006-0016-z. Curr HIV/AIDS Rep. 2006. PMID: 17089480 Review.

6

The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention.

Altice FL, Sullivan LE, Smith-Rohrberg D, Basu S, Stancliff S, Eldred L. Altice FL, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S178-83. doi: 10.1086/508181. Clin Infect Dis. 2006. PMID: 17109304 Review.

7

Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care.

Schackman BR, Merrill JO, McCarty D, Levi J, Lubinski C. Schackman BR, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S247-53. doi: 10.1086/508190. Clin Infect Dis. 2006. PMID: 17109311 Review.

8

Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.

Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, Cook K, Moore RD. Lucas GM, et al. Ann Intern Med. 2010 Jun 1;152(11):704-11. doi: 10.7326/0003-4819-152-11-201006010-00003. Ann Intern Med. 2010. PMID: 20513828 Free PMC article. Clinical Trial.

9

Integration of buprenorphine for substance-abuse treatment by HIV care providers.

Friedland G, Vlahov D. Friedland G, et al. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1:S1-2. doi: 10.1097/QAI.0b013e31820bc9ba. J Acquir Immune Defic Syndr. 2011. PMID: 21317588 No abstract available.

10

Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.

Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D; BHIVES Collaborative. Korthuis PT, et al. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S83-90. doi: 10.1097/QAI.0b013e31820bc9a5. J Acquir Immune Defic Syndr. 2011. PMID: 21317600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year